Company: BIVIW
Filing Date: 2025-08-04
Form Type: S-1/A
Source: 0001520138-25-000235
Chunk: 119

Company: BIOVIE INC.
Filing Date: 2025-08-04
Form: S-1/A
Chunk 119
---
 the vacancy shall hold
office for the balance of the term for which he or she was elected. A director appointed by the Board to fill the vacancy shall serve
until the next meeting of stockholders at which directors are elected.

A director need not be a stockholder. Directors shall not receive any
stated salary for their services as directors or as members of committees, but by resolution of the Board of Directors a fixed fee and
expenses of attendance may be allowed for attendance at each meeting. Our Amended and Restated Bylaws shall not be construed to preclude
any director from serving the Company in any other capacity as an officer, agent or otherwise, and receiving compensation therefor.

<div align='center'>61</div>

There are no familial relationships among any of our directors or officers.
Except as described under “The Nominees” above or “Executive Officers” below, none of our other directors or officers
is or has been a director or has held any form of directorship in any other U.S. reporting companies. None of our directors or officers
has been affiliated with any Company that has filed for bankruptcy within the last five years. We are not aware of any proceedings to
which any of our officers or directors, or any associate of any such officer or director, is a party that are adverse to the Company.
We are also not aware of any material interest of any of our officers or directors that is adverse to our own interests.

Code of Ethics

We have adopted a code of conduct and ethics meeting the requirements
of Section 406 of the Sarbanes-Oxley Act of 2002. We believe our code of conduct and ethics is reasonably designed to deter wrongdoing
and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with
applicable laws; ensure prompt internal reporting of violations; and provide accountability for adherence to the provisions of the code
of ethic. Our code of ethics is accessible under the “Investors-Governance” section of our website at www.bioviepharma.com.
Disclosure regarding any amendments to, or waivers from, provisions of the code of ethics will be included in a Current Report on Form
8-K that will be filed with the SEC within four business days following the date of the amendment or waiver.

Independence of the Board of Directors

Our common stock is traded on the Nasdaq Capital
Market. After review of all relevant transactions and relationships between each director, or any of the director’s